Evidence map›Paper›PMID 30895312›Full record

ArticleSleep2019

Extracellular vesicles reveal abnormalities in neuronal iron metabolism in restless legs syndrome.

Sahil Chawla, Seema Gulyani, Richard P Allen, Christopher J Earley, Xu Li, Peter Van Zijl, Dimitrios Kapogiannis

Open access · bronzeAbstract read
In one paragraph

Article in Sleep, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 23 citations in OpenAlex.

  1. Altered iron metabolism and iron therapy in restless legs syndrome.Journal of neural transmission (Vienna, Austria : 1996) · 2026
    Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. MRI findings in movement disorders and associated sleep disturbances.American journal of nuclear medicine and molecular imaging · 2023
    Review
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Iron and Alzheimer's Disease: From Pathology to Imaging.Frontiers in human neuroscience · 2022
    Review
  16. Synaptic and complement markers in extracellular vesicles in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2021
    Article
  17. Review
  18. Mitochondrial RNA in Alzheimer's Disease Circulating Extracellular Vesicles.Frontiers in cell and developmental biology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Sahil ChawlaLaboratory of Neurosciences, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD.
Seema GulyaniJohns Hopkins Sleep Disorders Center, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Richard P AllenDepartment of Neurology, The Johns Hopkins Center for Restless Legs Syndrome, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Christopher J EarleyDepartment of Neurology, The Johns Hopkins Center for Restless Legs Syndrome, Johns Hopkins Bayview Medical Center, Baltimore, MD.
Xu LiDepartment of Radiology and Radiological Science, Division of MR Research, Johns Hopkins Medicine, Baltimore, MD.
Peter Van ZijlDepartment of Radiology and Radiological Science, Division of MR Research, Johns Hopkins Medicine, Baltimore, MD.
Dimitrios KapogiannisLaboratory of Neurosciences, Intramural Research Program, National Institute on Aging, NIH, Baltimore, MD.
Johns Hopkins University · USNational Institute on Aging · US

Funding

Studies in Dementia and Neurodegenerative DiseasesZIAAG000975 · NIA · NATIONAL INSTITUTE ON AGING · PI KAPOGIANNIS, DIMITRIOS · 2009 to 2025
$31.5M
TR&D 4: Algorithms for functional and anatomical brain analysisP41EB015909 · NIBIB · HUGO W. MOSER RES INST KENNEDY KRIEGER · PI VAN ZIJL, PETER CM · 2012 to 2020
$13.1M
Neuroimaging, Behavioral Neurology and Development of 3T MRI projectsZIAAG000966 · NIA · NATIONAL INSTITUTE ON AGING · PI KAPOGIANNIS, DIMITRIOS · 2010 to 2025
$6.9M
Lymphocyte CpG methylation changes and brain pathology in Restless Legs SyndromeR01NS101283 · NINDS · JOHNS HOPKINS UNIVERSITY · PI EARLEY, CHRISTOPHER J · 2017 to 2021
$2.8M
Glutamate, hyperarousal and restless legs syndromeR01NS075184 · NINDS · JOHNS HOPKINS UNIVERSITY · PI ALLEN, RICHARD PUTNAM · 2012 to 2014
$1.2M
NIBIB NIH HHS P41 EB015909NINDS NIH HHS R01 NS075184NINDS NIH HHS R01 NS101283
6 · The paper itself

Abstract

STUDY

objectivesDetermine abnormalities in levels of iron-management proteins in neuronal origin-enriched extracellular vesicles (nEVs) in restless legs syndrome (RLS).

methodsWe used immunoprecipitation for neuronal marker L1CAM to isolate nEVs from the serum of 20 participants with RLS from a study including magnetic resonance imaging (MRI) determinations of iron deposition in the substantia nigra and hematologic parameters and 28 age- and sex-matched Controls.

resultsRLS compared with Control participants showed higher levels of nEV total ferritin but similar levels of transferrin receptor and ferroportin. Western blot analysis showed that heavy- but not light-chain ferritin was increased in nEVs of RLS compared with Control participants. In RLS but not Control participants, nEV total ferritin was positively correlated with systemic iron parameters; the two groups also differed in the relation of nEV total ferritin to MRI measures of iron deposition in substantia nigra.

conclusionsGiven the neuronal origin and diversity of EV cargo, nEVs provide an important platform for exploring the underlying pathophysiology and possible biomarkers of RLS.

Indexed as

Antigens, CDCation Transport ProteinsExtracellular VesiclesFemaleFerritinsFerroportinHumansIronMaleMiddle AgedNeural Cell Adhesion Molecule L1NeuronsReceptors, TransferrinRestless Legs SyndromeSubstantia NigraAntigens, CDCation Transport ProteinsCD71 antigenFerritinsFerroportinIronL1CAM protein, humanNeural Cell Adhesion Molecule L1Receptors, Transferrinexosomesextracellular vesiclesferritinironrestless legs syndrome

Identifiers

PMID30895312
PMCPMC6612672
OpenAlexW2922707357

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.